Svb Wealth LLC Amgen Inc Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $177,881 - $216,172	677 Added 2.35%	29,474 $9.21 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $415,135 - $501,120	1,544 Added 5.67%	28,797 $8.19 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $235,755 - $265,960	-922 Reduced 3.27%	27,253 $7.85 Million
Q3 2023 Oct 23, 2023	SELL	$218.65 - $271.46 $591,229 - $734,027	-2,704 Reduced 8.76%	28,175 $7.57 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $5.12 Million - $6.06 Million	-23,913 Reduced 43.64%	30,879 $6.86 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $688,433 - $839,084	-3,049 Reduced 5.27%	54,792 $13.2 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $1.78 Million - $2.26 Million	-7,755 Reduced 11.82%	57,841 $15.2 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $2.66 Million - $2.99 Million	11,830 Added 22.0%	65,596 $14.8 Million
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $60,215 - $67,009	261 Added 0.49%	53,766 $13.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $174,538 - $193,085	796 Added 1.51%	53,505 $12.9 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $46,537 - $53,258	-234 Reduced 0.44%	52,709 $11.9 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $68,138 - $79,832	-321 Reduced 0.6%	52,943 $11.3 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $277,025 - $307,340	-1,186 Reduced 2.18%	53,264 $13 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $55,921 - $65,167	-252 Reduced 0.46%	54,450 $13.5 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $68,808 - $81,939	318 Added 0.58%	54,702 $12.6 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $664,059 - $738,488	-2,830 Reduced 4.95%	54,384 $13.8 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $431,027 - $528,930	-2,179 Reduced 3.67%	57,214 $13.5 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $406,941 - $539,716	-2,233 Reduced 3.62%	59,393 $12 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $558,169 - $717,440	-2,950 Reduced 4.57%	61,626 $14.9 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $1.57 Million - $1.88 Million	-9,014 Reduced 12.25%	64,576 $12.5 Million
Q2 2019 Jul 10, 2019	SELL	$166.7 - $195.41 $290,058 - $340,013	-1,740 Reduced 2.31%	73,590 $13.6 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $826,575 - $931,731	-4,570 Reduced 5.72%	75,330 $14.3 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $725,552 - $846,952	-4,067 Reduced 4.84%	79,900 $15.6 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $288,681 - $325,450	-1,558 Reduced 1.82%	83,967 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $696,911 - $782,782	-4,197 Reduced 4.68%	85,525 $15.8 Million
Q1 2018 May 11, 2018	BUY	$169.43 - $198.0 $238,896 - $279,180	1,410 Added 1.6%	89,722 $15.3 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $607,981 - $679,301	-3,602 Reduced 3.92%	88,312 $15.4 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $15.4 Million - $17.6 Million	91,914	91,914 $17.1 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account